Complete Blood Count (CBC) with Differential
The Complete Blood Count with Differential quantifies and characterises white blood cells (with 5-part leucocyte differential), red blood cells (with erythrocyte indices including MCV, MCH, MCHC, and RDW), and platelets (with mean platelet volume) from a single EDTA whole blood specimen.
3
Biomarkers
Blood (whole blood)
Sample
1–2 business days
Turnaround
No — fasting is not required for the CBC and does not affect haematological parameters. However, if the CBC is collected alongside fasting lipid or metabolic panels as part of a Boston Heart Diagnostics comprehensive cardiovascular assessment, collection should be timed to meet the fasting requirement of the companion tests.
Fasting
What is the CBC with Differential test?
The Complete Blood Count with Differential is the most widely ordered haematological laboratory test in clinical practice, providing simultaneous quantification and characterisation of the three major formed elements of blood — white blood cells (with 5-part leucocyte differential), red blood cells (with erythrocyte indices), and platelets (with mean platelet volume) — from a single EDTA whole blood specimen. The CBC provides a comprehensive haematological baseline that simultaneously screens for anaemia and its morphological type, immune system abnormalities ranging from reactive leucocytosis to leucopenia, thrombocytopenia and thrombocytosis, and early haematoproliferative disease — within a single low-cost, high-yield laboratory order. Boston Heart Diagnostics is a specialty cardiovascular diagnostics laboratory; in this context, the CBC serves both as a general health safety baseline and as a source of cardiovascular-relevant haematological parameters — particularly haemoglobin (anaemia worsens cardiovascular outcomes), RDW (an independent predictor of major adverse cardiovascular events), MPV (emerging platelet reactivity and thrombotic risk marker), and the neutrophil-to-lymphocyte ratio (NLR — an inflammatory cardiovascular risk index gaining traction in preventive cardiology). Within the diagnostic landscape, the CBC is typically the first-line haematological test in any clinical presentation involving fatigue, dyspnoea, pallor, infection, unexplained weight loss, lymphadenopathy, easy bruising or bleeding, or abnormal findings on examination suggesting haematological pathology. It is a mandatory component of any comprehensive metabolic or cardiovascular health panel, providing the haematological safety baseline against which all pharmacological therapies are assessed and monitored. When CBC findings are abnormal — particularly when leucopenia, severe anaemia, thrombocytopenia, blast cells on differential, or markedly elevated leucocyte counts are present — reflex investigation with peripheral blood film, reticulocyte count, iron studies, B12, folate, haematinics, and haematology specialist review is indicated.
What does the CBC with Differential test measure?
White blood cells are the cellular mediators of innate and adaptive immune defence, produced in the bone marrow from haematopoietic stem cells under the regulation of colony-stimulating factors and cytokines. The five leucocyte subtypes detected by automated 5-part differential analysis are mechanistically distinct: neutrophils are the first-responder phagocytes of acute bacterial and fungal infection; lymphocytes are the T-cell, B-cell, and NK-cell mediators of adaptive immunity and viral defence; monocytes are the precursors to tissue macrophages and dendritic cells, central to chronic inflammation and antigen presentation; eosinophils mediate allergic and parasitic responses via cytotoxic granule release; and basophils, the least abundant circulating leucocyte, participate in IgE-mediated hypersensitivity responses. The absolute count for each subtype — derived by multiplying the differential percentage by the total WBC — carries greater clinical utility than the percentage alone, as absolute counts are not affected by changes in other leucocyte populations.
The WBC count and differential is the foundational haematological immune screen, providing simultaneous assessment of infectious, inflammatory, allergic, and haematoproliferative conditions. Neutrophilia with a left shift (circulating band cells) indicates acute bacterial infection or physiological stress response. Lymphocytosis with reactive lymphocytes suggests viral infection — particularly EBV and CMV. Eosinophilia prompts evaluation for atopic disease, parasitic infection, or eosinophilic organ infiltration. Monocytosis is associated with chronic infection (tuberculosis, subacute bacterial endocarditis), inflammatory bowel disease, and monocytic leukaemia. In Boston Heart Diagnostics' cardiovascular-focused clinical context, the neutrophil-to-lymphocyte ratio (NLR) and monocyte count are emerging inflammatory cardiovascular risk markers — elevated NLR has been associated with adverse cardiovascular outcomes independent of traditional risk factors.
Erythrocytes are anucleate biconcave discs produced by erythropoiesis in the bone marrow under erythropoietin (EPO) stimulation, which is regulated by renal oxygen-sensing cells responding to tissue hypoxia. Each erythrocyte contains approximately 270 million haemoglobin molecules — the iron-porphyrin oxygen-transport protein — and has a circulating lifespan of approximately 120 days before phagocytosis by splenic and hepatic reticuloendothelial macrophages. The erythrocyte indices derived by automated cell counter analysis characterise the size (MCV — mean corpuscular volume), haemoglobin content (MCH — mean corpuscular haemoglobin), haemoglobin concentration (MCHC — mean corpuscular haemoglobin concentration), and size distribution (RDW — red cell distribution width) of the circulating erythrocyte population, enabling morphological characterisation of anaemia type without requiring manual microscopic review in most cases.
The erythrocyte indices are the primary tool for anaemia characterisation and differential diagnosis. MCV-based classification divides anaemia into microcytic (MCV <80 fL — iron deficiency, thalassaemia, sideroblastic anaemia, anaemia of chronic disease), normocytic (MCV 80–100 fL — anaemia of chronic disease, haemolysis, early mixed deficiency), and macrocytic (MCV >100 fL — B12 or folate deficiency, hypothyroidism, liver disease, medication effect including methotrexate and hydroxyurea). RDW elevation indicates anisocytosis — heterogeneity in erythrocyte size — which occurs early in iron deficiency before MCV falls and is a sensitive early marker of nutritional deficiency. In cardiovascular medicine, haemoglobin, haematocrit, and RDW carry independent prognostic significance — anaemia worsens cardiovascular outcomes and elevated RDW is an independent predictor of major adverse cardiovascular events.
Platelets are anucleate cytoplasmic fragments derived from megakaryocyte fragmentation in the bone marrow, produced under thrombopoietin (TPO) regulation with a circulating lifespan of 8–12 days. They are the primary cellular mediators of primary haemostasis — adhering to exposed subendothelial collagen via von Willebrand factor (vWF) and glycoprotein Ib-IX, activating, releasing granule contents (ADP, serotonin, thromboxane A2), and aggregating to form the primary platelet plug before coagulation cascade amplification. Mean platelet volume (MPV) reflects the average size of circulating platelets — larger platelets are metabolically more active, contain more granules, and have greater thrombogenic potential than smaller platelets.
Platelet count assessment identifies thrombocytopenia — platelet count below 150 ×10³/µL — which may indicate immune thrombocytopenic purpura (ITP), drug-induced thrombocytopenia, bone marrow suppression, splenic sequestration, or consumptive coagulopathy (DIC, TTP, HUS) — and thrombocytosis — above 400 ×10³/µL — which may reflect reactive thrombocytosis from iron deficiency, inflammation, or post-splenectomy state, or essential thrombocythaemia. MPV carries emerging cardiovascular significance — elevated MPV has been associated with increased platelet reactivity, platelet aggregation, and higher risk of arterial thrombotic events including myocardial infarction and stroke, making it a relevant biomarker within Boston Heart Diagnostics' cardiovascular risk assessment context.
Why is the CBC with Differential test ordered?
- Comprehensive cardiovascular health baseline — CBC as part of Boston Heart Diagnostics' cardiovascular risk assessment framework, providing haemoglobin, RDW, and MPV as haematological cardiovascular risk markers alongside Boston Heart's lipid, inflammatory, and metabolic panels
- Anaemia evaluation — unexplained fatigue, dyspnoea on exertion, pallor, or exertional intolerance where haemoglobin and erythrocyte indices characterise the presence, severity, and morphological type of anaemia to direct the next diagnostic step
- Infection and inflammatory workup — leucocytosis or leucopenia investigation in patients with fever, systemic illness, or unexplained constitutional symptoms, with the differential providing the leucocyte pattern to distinguish bacterial from viral from allergic from haematoproliferative causes
- Pre-medication safety baseline — CBC before initiating pharmacotherapy associated with haematological adverse effects including chemotherapy, methotrexate, azathioprine, clozapine, carbimazole, and anticoagulants, establishing a baseline for subsequent monitoring
- Routine health maintenance screening — annual CBC as part of preventive health monitoring in adults, particularly those with cardiovascular disease, diabetes, chronic kidney disease, autoimmune conditions, or on long-term medications affecting bone marrow or haematological parameters
- Thrombocytopenia and bleeding tendency assessment — easy bruising, petechiae, prolonged bleeding, or incidental low platelet count found on routine testing, with platelet count and MPV guiding the urgency and direction of investigation
- Nutritional deficiency monitoring — CBC for haematological response to iron, B12, or folate repletion in patients with confirmed nutritional deficiency anaemia, tracking MCV normalisation and haemoglobin recovery
- Post-treatment and oncology monitoring — CBC for haematological toxicity assessment in patients receiving chemotherapy, radiation, or immunosuppressive therapy, providing white cell, red cell, and platelet nadirs to guide dose modification and supportive care decisions
Sample collection and turnaround
Sample type
Blood (whole blood)
Fasting required
No — fasting is not required for the CBC and does not affect haematological parameters. However, if the CBC is collected alongside fasting lipid or metabolic panels as part of a Boston Heart Diagnostics comprehensive cardiovascular assessment, collection should be timed to meet the fasting requirement of the companion tests.
Collection method
Venipuncture at patient service centre
Turnaround
1–2 business days
Collection notes
Collect into EDTA tube (lavender / purple top). Immediately after collection, gently invert the tube 8–10 times — thorough mixing is critical to prevent microclot formation and platelet clumping, which causes pseudothrombocytopenia. Do not shake the tube vigorously — this causes haemolysis. Transport and deliver the specimen to Boston Heart Diagnostics within 6–8 hours of collection at ambient temperature (18–25°C) to preserve WBC morphology and platelet integrity. Do not refrigerate EDTA whole blood specimens intended for differential analysis — cold agglutination and platelet swelling occur at refrigerator temperature for whole blood. Document current medications — particularly corticosteroids, immunosuppressants, and chemotherapy — on the requisition form, as these directly affect all CBC parameters. # REVIEWER FLAG: Confirm Boston Heart Diagnostics' specific EDTA tube type, required fill volume, maximum transit time, temperature requirements, and any special handling instructions before publication.
Specimen requirements
Minimum 3.0 mL EDTA whole blood (standard 4.0 mL EDTA draw). Specimen must be analysed within 6–8 hours of collection at ambient temperature for optimal differential and morphology accuracy. Do not freeze whole blood specimens. # REVIEWER FLAG: Confirm minimum volume requirement and maximum time from collection to analysis with Boston Heart Diagnostics.
What can affect CBC with Differential results?
EDTA anticoagulated whole blood for CBC must be gently inverted 8–10 times immediately after collection to ensure thorough anticoagulation and prevent microclot formation. Insufficient mixing causes platelet clumping — producing falsely low platelet counts (pseudothrombocytopenia) that can trigger inappropriate clinical investigation. Specimens left unanalysed at room temperature for more than 6–8 hours show progressive WBC morphology deterioration, platelet swelling (artefactually elevated MPV), and RBC spherocytosis, compromising differential and indices accuracy. Specimens should be transported and analysed promptly per Boston Heart Diagnostics' specimen handling protocol.
Acute physiological stress — strenuous exercise, emotional distress, infection, surgery, trauma, or pain — triggers catecholamine-mediated demargination of neutrophils from the endothelial wall into the circulating pool, causing transient leucocytosis and neutrophilia (physiological leucocytosis) without underlying pathology. This effect resolves within hours. WBC results obtained immediately following vigorous exercise, acutely stressful events, or during active systemic illness should be contextualised accordingly and not attributed to primary haematological pathology without confirmation.
Chronic cigarette smoking causes persistent leucocytosis — predominantly neutrophilia — through ongoing airway inflammation, increased cytokine-driven bone marrow stimulation, and reduced neutrophil apoptosis. Smokers have WBC counts averaging 1–2 ×10³/µL higher than age-matched non-smokers at equivalent baseline health. Smoking history should be documented and factored into WBC interpretation — persistent leucocytosis in an otherwise well smoker may not warrant haematological investigation if smoking is the plausible cause.
Iron deficiency produces microcytic, hypochromic erythrocytes (low MCV, low MCH, low MCHC) with elevated RDW as the earliest indicator of erythrocyte size heterogeneity — often preceding MCV fall by weeks. Concurrent iron deficiency can produce thrombocytosis through shared EPO-thrombopoietin pathway stimulation and may cause reactive leucocytosis. Ferritin should be assessed concurrently when microcytic or high-RDW anaemia is identified to confirm iron deficiency as the mechanism.
Systemic corticosteroids produce a characteristic haematological pattern: neutrophilia (demargination and reduced apoptosis), lymphopenia (redistribution to lymphoid tissue), eosinopenia (sequestration), and monocytopenia — a pattern termed the 'steroid differential' that should not be misinterpreted as bacterial infection-pattern leucocytosis. Corticosteroid dose and duration must be documented when interpreting CBC differential results in patients on glucocorticoid therapy.
Residence at high altitude chronically stimulates EPO production via hypoxia-inducible factor (HIF) pathways, producing secondary erythrocytosis — elevated RBC, haemoglobin, and haematocrit. Haemoconcentration from dehydration at collection similarly elevates haemoglobin and haematocrit. Altitude of habitual residence and hydration status at collection should be documented when erythrocytosis is identified to distinguish secondary from primary (polycythaemia vera) causes.
What do CBC with Differential results mean?
Elevated
Elevated WBC (leucocytosis >10.5 ×10³/µL) requires differential pattern analysis: neutrophilia suggests acute bacterial infection, physiological stress, corticosteroid effect, or myeloid malignancy; lymphocytosis with reactive forms suggests viral infection (EBV, CMV) or chronic lymphocytic leukaemia in older patients; eosinophilia prompts evaluation for atopy, parasitic infection, or eosinophilic disorders; monocytosis suggests chronic infection, inflammatory disease, or monocytic leukaemia. Elevated haemoglobin or haematocrit (erythrocytosis) requires assessment for secondary causes (altitude, smoking, EPO-producing tumour, sleep apnoea) before primary polycythaemia vera is considered. Elevated platelets (thrombocytosis >400 ×10³/µL) are most commonly reactive — from iron deficiency, infection, inflammation, or post-splenectomy — with essential thrombocythaemia a consideration when reactive causes are excluded and counts persistently exceed 600–800 ×10³/µL.
Normal
A fully normal CBC with differential in a symptomatic patient does not exclude all haematological pathology — early myelodysplastic syndrome, early lymphoma, and some inherited haemolytic conditions can present with a normal CBC before progressing to overt cytopenias. A normal CBC does provide robust reassurance that common haematological causes of the presenting symptoms — anaemia, infection-pattern leucocytosis, thrombocytopenia — are absent at the time of testing. In cardiovascular medicine, a normal haemoglobin and low-normal RDW and MPV within the reference range are associated with better cardiovascular prognosis than high-normal values for these parameters.
Reduced
Leucopenia (WBC <4.0 ×10³/µL) — particularly neutropenia (ANC <1.8 ×10³/µL) — requires clinical urgency assessment: ANC <0.5 ×10³/µL is severe neutropenia warranting urgent haematological review. Causes include bone marrow suppression (chemotherapy, radiation, medication), viral infections (HIV, EBV, parvovirus B19), autoimmune neutropenia, and haematological malignancy. Anaemia — haemoglobin below sex-specific lower limit — triggers MCV-based morphological classification to direct specific deficiency or disease investigation. Thrombocytopenia (<150 ×10³/µL) requires immediate assessment of severity and bleeding risk: counts below 50 ×10³/µL carry significant spontaneous bleeding risk; counts below 20 ×10³/µL are a haematological emergency requiring same-day specialist review.
Note: The CBC is an automated haematology analyser output — it identifies quantitative abnormalities and applies morphological flags, but cannot replace peripheral blood film microscopy for definitive cell morphology assessment. When the analyser flags abnormal populations — blasts, atypical lymphocytes, giant platelets, fragmented red cells, or NRBC — a manual microscopic review by a haematologist or haematology scientist is required before clinical decisions are based on the result. Pseudothrombocytopenia from EDTA-induced platelet clumping is a significant pre-analytical artefact that can produce falsely low platelet counts — when platelet count is unexpectedly low without clinical bleeding evidence, request citrate or heparin anticoagulant tube recount or manual film count to exclude platelet clumping before initiating thrombocytopenia investigation.
Frequently asked questions
The CBC with Differential measures three major blood cell populations simultaneously: white blood cells (total count plus the proportion and absolute number of neutrophils, lymphocytes, monocytes, eosinophils, and basophils); red blood cells (count, haemoglobin, haematocrit, and erythrocyte size and haemoglobin content indices — MCV, MCH, MCHC, and RDW); and platelets (count and mean platelet volume). Together these parameters screen for anaemia, immune system abnormalities, infectious processes, and platelet disorders from a single blood draw.
How to access the CBC with Differential test
The CBC with Differential reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: May 23, 2026
Last reviewed: May 23, 2026
- Bain BJ. Blood cells: a practical guide. 5th ed. Wiley-Blackwell. (2015)
- Lippi G, et al. Red blood cell distribution width: a key laboratory test for the prediction of morbidity and mortality in hospitalized patients. Clin Chim Acta. (2014)
- Bhat T, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. (2013)
- Slavka G, et al. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol. (2011)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.
Related tests
metabolic diabetes
CMP
The Comprehensive Metabolic Panel is a 14-analyte serum chemistry panel simultaneously evaluating renal function (creatinine, BUN, eGFR), hepatic function (ALT, AST, total bilirubin, albumin, total protein), metabolic status (glucose, calcium), and electrolyte-acid-base homeostasis (sodium, potassium, chloride, bicarbonate) from a single fasting serum specimen.
vitamins minerals
Ferritin
The Ferritin test measures serum ferritin, the circulating form of the body's principal iron-storage protein, as the standard indirect measure of total body iron stores. A low ferritin is the most specific routine marker of iron deficiency, while a high ferritin indicates iron overload or, commonly, an acute-phase inflammatory response.